The abuse potential of prolintane in rodents: Behavioral pharmacology approaches
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 205, 108917
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Food and Drug Safety (19181MFDS402)
This publication has 29 references indexed in Scilit:
- Dopamine in drug abuse and addiction: results from imaging studies and treatment implicationsMolecular Psychiatry, 2004
- Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in ratsNeuroscience, 2004
- Visual Hallucinations Induced by the Combination of Prolintane and DiphenhydraminePharmacopsychiatry, 2002
- MDMA Elicits Behavioral and Neurochemical Sensitization in RatsNeuropsychopharmacology, 1998
- A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulantsBrain Research Reviews, 1997
- Rat climbing behavior elicited by stimulation of cerebral dopamine receptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 1984
- Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvementEuropean Journal of Pharmacology, 1982
- Wakefullness and reduced rapid eye movement sleep: studies with prolintane and pemoline.1980
- Effects of prolintane on 3,4-dihydroxyphenylacetic acid concentration in rat brain after spiperone treatmentPharmacology Biochemistry and Behavior, 1979
- The effect of amphetamine on the sleep cycleElectroencephalography and Clinical Neurophysiology, 1964